• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
76,802.90 -607.08
( -0.78%)
Global Indices
Nasdaq
51,585.70 72.15
(0.14%)
Dow Jones
7,521.58 80.48
(1.08%)
Hang Seng
70,971.12 -82.37
(-0.12%)
Nikkei 225
10,357.71 -41.99
(-0.40%)
Forex
USD-INR
94.39 -0.12
(-0.13%)
EUR-INR
108.40 -1.03
(-0.94%)
GBP-INR
125.08 -1.43
(-1.13%)
JPY-INR
0.59 0.00
(-0.50%)

EQUITY - MARKET SCREENER

Krebs Biochemicals & Industries Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs
BSE Code
ISIN Demat
Book Value()
524518
INE268B01013
-75.4893276
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
KREBSBIO
0
142.24
EPS(TTM)
Face Value()
Div & Yield %
0
10
0
 
( Cr)
ParticularsMar 2026 ( Cr)Dec 2025 ( Cr)Sep 2025 ( Cr)
Gross Sales6.817.274.17
Other Operating Income0.000.000.00
Other Income 2.000.000.01
Total Income8.817.284.17
Total Expenditure 7.686.986.96
PBIDT1.140.30-2.79
Interest 1.911.791.73
PBDT-0.77-1.49-4.52
Depreciation1.571.631.62
Tax0.000.000.00
Fringe Benefit Tax0.000.000.00
Deferred Tax0.000.000.00
Reported Profit After Tax-2.34-3.13-6.14
Extra-ordinary Items 0.000.000.00
Adjusted Profit After Extra-ordinary item-2.34-3.13-6.14
EPS (Unit Curr.)-1.09-1.45-2.85
EPS (Adj) (Unit Curr.)-1.09-1.45-2.85
Calculated EPS (Unit Curr.)-1.09-1.45-2.85
Calculated EPS (Adj) (Unit Curr.)-1.09-1.45-2.85
Calculated EPS (Ann.) (Unit Curr.)-4.34-5.80-11.40
Calculated EPS (Adj) (Ann.) (Unit Curr.)-4.34-5.80-11.40
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.000.000.00
Equity21.5621.5621.56
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)16.744.13-66.91
PBDTM(%)-11.31-20.50-108.39
PATM(%)-34.36-43.05-147.24